Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $953.26 | 13 | 99.7% |
| Education | $2.86 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $256.73 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $132.38 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $125.00 | 1 | $0 (2020) |
| Mallinckrodt LLC | $120.20 | 1 | $0 (2017) |
| Fresenius USA Marketing, Inc. | $108.52 | 1 | $0 (2019) |
| BAXTER HEALTHCARE | $92.17 | 3 | $0 (2019) |
| Amgen Inc. | $83.87 | 1 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $21.66 | 1 | $0 (2017) |
| NxStage Medical, Inc. | $12.73 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $216.25 | 3 | Novartis Pharmaceuticals Corporation ($132.38) |
| 2023 | $145.71 | 1 | Bayer Healthcare Pharmaceuticals Inc. ($145.71) |
| 2022 | $111.02 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($111.02) |
| 2021 | $1.92 | 1 | Travere Therapeutics, Inc. ($1.92) |
| 2020 | $125.00 | 1 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2019 | $153.23 | 4 | Fresenius USA Marketing, Inc. ($108.52) |
| 2017 | $202.99 | 4 | Mallinckrodt LLC ($120.20) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $83.87 | General |
| 10/02/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $78.36 | General |
| Category: Immunology | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $54.02 | General |
| Category: Immunology | ||||||
| 09/20/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $145.71 | General |
| Category: Cardio-renal | ||||||
| 12/13/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $111.02 | General |
| Category: Cardio-renal | ||||||
| 02/25/2021 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $1.92 | General |
| Category: Kidney Stones | ||||||
| 03/05/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2019 | NxStage Medical, Inc. | — | Food and Beverage | In-kind items and services | $12.73 | General |
| 10/12/2019 | Fresenius USA Marketing, Inc. | Critline - Monitors (Device) | Food and Beverage | In-kind items and services | $108.52 | General |
| Category: System, Hemodialysis, Access Recirculation Monitoring | ||||||
| 10/02/2019 | BAXTER HEALTHCARE | Renal - PD (Device) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Renal | ||||||
| 10/02/2019 | BAXTER HEALTHCARE | Renal - PD (Device) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Renal | ||||||
| 11/29/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $120.20 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 09/19/2017 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Hyperparathyroidism | ||||||
| 08/07/2017 | BAXTER HEALTHCARE | Renal - Non Product Related (Biological) | Food and Beverage | In-kind items and services | $60.19 | General |
| Category: Renal | ||||||
| 07/17/2017 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $0.94 | General |
| Category: Kidney Stones | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 279 | 443 | $114,609 | $49,980 |
| 2022 | 7 | 246 | 443 | $91,201 | $44,842 |
| 2021 | 8 | 248 | 387 | $66,038 | $33,745 |
| 2020 | 8 | 232 | 369 | $68,980 | $28,260 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 17 | 78 | $46,020 | $20,702 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 188 | $38,344 | $16,204 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $12,484 | $5,096 | 40.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 73 | $8,573 | $4,387 | 51.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 19 | $4,226 | $1,848 | 43.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 20 | 22 | $3,150 | $1,206 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $1,812 | $535.80 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 159 | $27,921 | $14,092 | 50.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 13 | 47 | $23,947 | $12,896 | 53.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 64 | 64 | $17,304 | $8,086 | 46.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 114 | $13,152 | $5,924 | 45.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 17 | $3,756 | $1,650 | 43.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 21 | $2,564 | $1,145 | 44.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 17 | 21 | $2,557 | $1,049 | 41.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 182 | $31,122 | $16,300 | 52.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 50 | 50 | $13,200 | $6,117 | 46.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 30 | 64 | $7,232 | $3,626 | 50.1% |
| G0426 | Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | Facility | 2021 | 15 | 18 | $2,880 | $1,928 | 67.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $3,816 | $1,722 | 45.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 19 | 25 | $2,700 | $1,595 | 59.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 19 | $3,116 | $1,547 | 49.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 17 | $1,972 | $910.57 | 46.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 56 | 56 | $14,784 | $7,038 | 47.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 79 | $13,509 | $6,591 | 48.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 41 | 95 | $15,212 | $5,539 | 36.4% |
About Dr. Gopal Chemiti, MD
Dr. Gopal Chemiti, MD is a Nephrology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740207745.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gopal Chemiti, MD has received a total of $956.12 in payments from pharmaceutical and medical device companies, with $216.25 received in 2024. These payments were reported across 15 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($953.26).
As a Medicare-enrolled provider, Chemiti has provided services to 1,005 Medicare beneficiaries, totaling 1,642 services with total Medicare billing of $156,827. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Salt Lake City, UT
- Active Since 07/16/2006
- Last Updated 06/02/2022
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1740207745
Products in Payments
- Kerendia (Drug) $256.73
- Fabhalta (Drug) $132.38
- LOKELMA (Drug) $125.00
- ACTHAR (Biological) $120.20
- Critline - Monitors (Device) $108.52
- Renal - Non Product Related (Biological) $60.19
- Renal - PD (Device) $31.98
- Rayaldee (Drug) $21.66
- Thiola (Drug) $1.92
- (815) Thiola (Drug) $0.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Salt Lake City
Alfred Cheung, Md, MD
Nephrology — Payments: $169,239
Donald Kohan, Md, MD
Nephrology — Payments: $154,658
Fuad Shihab, Md, MD
Nephrology — Payments: $133,104
Srinivasan Beddhu, Md, MD
Nephrology — Payments: $8,338
Abinash Roy, Md, MD
Nephrology — Payments: $641.61
Christof Westenfelder, Md, MD
Nephrology — Payments: $386.59